Literature DB >> 14578092

Acitretin suppression of squamous cell carcinoma: case report and literature review.

M Lebwohl1, C Tannis, D Carrasco.   

Abstract

Retinoids have been used for the treatment and suppression of cutaneous malignancies in patients with basal cell nevus syndrome, xeroderma pigmentosum, and in patients with recurrent skin cancers as a result of immunosuppression for renal transplantation. We report a 40-year-old male who began to develop multiple squamous cell carcinomas of the skin after treatment with PUVA for severe psoriasis. The numbers of squamous cell carcinomas increased when acitretin was discontinued and decreased when he was taking the drug at a dose of 25 mg daily. Acitretin should be considered as a maintenance therapy for psoriasis patients developing squamous cell carcinomas as a result of PUVA therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578092     DOI: 10.1080/jdt.14.s2.3.6

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

1.  Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer.

Authors:  Joel L Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

2.  Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.

Authors:  Yan Zhao; Yanting Zhu; Haiqing Wang; Chao Ji
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

3.  Rare variants in drug target genes contributing to complex diseases, phenome-wide.

Authors:  Shefali Setia Verma; Navya Josyula; Anurag Verma; Xinyuan Zhang; Yogasudha Veturi; Frederick E Dewey; Dustin N Hartzel; Daniel R Lavage; Joe Leader; Marylyn D Ritchie; Sarah A Pendergrass
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

4.  Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1.

Authors:  Xiu-Ying Lin; Chun-Di He; Ting Xiao; Xin Jin; Jiang Chen; Ya-Kun Wang; Mei Liu; Kai-Bo Wang; Yi Jiang; Hua-Chen Wei; Hong-Duo Chen
Journal:  J Cell Mol Med       Date:  2009-06-20       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.